2022 | Clonal haematopoiesis is associated with higher mortality in patients with cardiogenic shock
https://pmccbiobank.ca/wp-content/themes/osmosis/images/empty/thumbnail.jpg 150 150 sabrina.agostini@uhn.ca sabrina.agostini@uhn.ca https://secure.gravatar.com/avatar/b61021141fafd1778f9d8d649e43b1e9?s=96&d=mm&r=g
Authors: Fernando L. Scolari, Sagi Abelson, Darshan H. Brahmbhatt, Sagi Abelson, Jessie J.F. Medeiros, Chun-Po S. Fan, Nicole L. Fung, Vesna Mihajlovic, Markus S. Anker, Madison Otsuki, Patrick R. Lawler, Heather J. Ross, Adriana C. Luk, Stefan Anker, John E. Dick, Filio Billia
Short Description: Cardiogenic shock (CS) with variable systemic inflammation may be responsible for patient heterogeneity and the exceedingly high mortality rate. Cardiovascular events have been associated with clonal haematopoiesis (CH) where specific gene mutations in haematopoietic stem cells lead to clonal expansion and the development of inflammation. This study aims to assess the prevalence of CH and its association with survival in a population of CS patients in a quaternary centre.
Interest: Cardiogenic Shock, Genomics, Heart Disease, Heart Failure, Molecular Biology
